18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis (Q37996935)

26 August 2017

0 references

18F-FDG-PET evaluation of treatment response to neo-adjuvant therapy in patients with locally advanced rectal cancer: a meta-analysis (English)

1 reference

26 August 2017

1 reference

Chenpeng Zhang

1

1 reference

26 August 2017

Jinlu Tong

2

1 reference

26 August 2017

Xiaoguang Sun

3

1 reference

26 August 2017

Jianjun Liu

4

1 reference

26 August 2017

Yuting Wang

5

1 reference

26 August 2017

Gang Huang

6

1 reference

26 August 2017

language of work or name

English

0 references

publication date

28 June 2012

1 reference

International Journal of Cancer

26 August 2017

published in

1 reference

26 August 2017

volume

131

1 reference

26 August 2017

issue

11

1 reference

26 August 2017

page(s)

2604-2611

1 reference

Preoperative radiotherapy with or without concurrent fluorouracil and leucovorin in T3-4 rectal cancers: results of FFCD 9203.

26 August 2017

cites work

1 reference

Non-operative treatment after neoadjuvant chemoradiotherapy for rectal cancer

21 January 2018

1 reference

18Fluoro-deoxy-glucose positron emission tomography in assessing tumor response to preoperative chemoradiation therapy for locally advanced rectal cancer.

21 January 2018

1 reference

Blood glucose level normalization and accurate timing improves the accuracy of PET-based treatment response predictions in rectal cancer

21 January 2018

1 reference

Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis

21 January 2018

1 reference

Prediction of tumor response to neoadjuvant therapy in patients with esophageal cancer with use of 18F FDG PET: a systematic review

21 January 2018

1 reference

The "y" symbol: an important classification tool for neoadjuvant cancer treatment

21 January 2018

1 reference

The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews

21 January 2018

1 reference

Metabolic response of rectal cancer assessed by 18-FDG PET following chemoradiotherapy is prognostic for patient outcome.

21 January 2018

1 reference

Evaluation of ¹⁸F-FDG-PET for early detection of suboptimal response of rectal cancer to preoperative chemoradiotherapy: a prospective analysis.

21 January 2018

1 reference

The value of metabolic imaging to predict tumour response after chemoradiation in locally advanced rectal cancer

21 January 2018

1 reference

The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer.

21 January 2018

1 reference

Prediction of response to neoadjuvant radiotherapy in patients with locally advanced rectal cancer by means of sequential 18FDG-PET.

21 January 2018

1 reference

(18)F-FDG PET bio-metabolic monitoring of neoadjuvant therapy effects in rectal cancer: focus on nodal disease characteristics

21 January 2018

1 reference

The predictive value of metabolic response to preoperative radiochemotherapy in locally advanced rectal cancer measured by PET/CT.

21 January 2018

1 reference

Change in glucose metabolism measured by 18F-FDG PET/CT as a predictor of histopathologic response to neoadjuvant treatment in rectal cancer.

21 January 2018

1 reference

Accuracy of MRI and 18F-FDG PET/CT for restaging after preoperative concurrent chemoradiotherapy for rectal cancer

21 January 2018

1 reference

The role of dual-time combined 18-fluorodeoxyglucose positron emission tomography and computed tomography in the staging and restaging workup of locally advanced rectal cancer, treated with preoperative chemoradiation therapy and radical surgery.

21 January 2018

1 reference

Can an FDG-PET/CT predict tumor clearance of the mesorectal fascia after preoperative chemoradiation of locally advanced rectal cancer?

21 January 2018

1 reference

Response to preoperative short-course radiotherapy in locally advanced rectal cancer: value of f-fluorodeoxyglucose positron emission tomography

21 January 2018

1 reference

PET/CT and histopathologic response to preoperative chemoradiation therapy in locally advanced rectal cancer

21 January 2018

1 reference

Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging?

21 January 2018

1 reference

Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: a means for determining longterm outcomes of rectal cancer

21 January 2018

1 reference

Restaging after neoadjuvant chemoradiotherapy for rectal adenocarcinoma: role of F18-FDG PET.

21 January 2018

1 reference

Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: correlation with endorectal ultrasound and histopathology

21 January 2018

1 reference

FDG-PET after radiotherapy is a good prognostic indicator of rectal cancer

21 January 2018

1 reference

Monitoring and predicting response to therapy with 18F-FDG PET in colorectal cancer: a systematic review.

21 January 2018

1 reference

Prospective study on the FDG-PET/CT predictive and prognostic values in patients treated with neoadjuvant chemoradiation therapy and radical surgery for locally advanced rectal cancer

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.27557

1 reference

26 August 2017

1 reference